T1	Procedure 156 159	ECG
T2	Procedure 335 342	therapy
T3	Procedure 439 451	implantation
T4	Procedure 551 558	surgery
T5	Procedure 804 811	surgery
T6	Procedure 1224 1235	reoperation
T7	Procedure 1408 1419	Replacement
T8	Procedure 1624 1631	removal
T9	Procedure 1884 1891	surgery
T10	Procedure 2013 2020	surgery
T11	Procedure 2240 2247	Surgery
T12	Procedure 2460 2467	primary
T13	Procedure 2622 2633	reoperation
T14	Procedure 2654 2662	surgical
T15	Procedure 2787 2796	tamponade
T16	Procedure 2973 2981	analysis
T17	Procedure 3081 3088	surgery
T18	Procedure 3269 3271	mg
T19	Procedure 3291 3311	creatinine clearance
T20	Procedure 3291 3301	creatinine
T21	Procedure 3381 3391	prevention
T22	Procedure 3641 3651	procedures
T23	Procedure 3652 3659	surgery
T24	Procedure 3794 3801	surgery
T25	Procedure 4107 4114	surgery
T26	Procedure 4612 4619	surgery
T27	Procedure 4718 4725	surgery
T28	Procedure 4818 4825	surgery
T29	Procedure 152 159	His ECG
T30	Procedure 316 368	long-term warfarin therapy with a CHADS 2 score of 5
T31	Procedure 439 496	implantation of a cardiac resynchronization defibrillator
T32	Procedure 540 558	the device surgery
T33	Procedure 748 811	a number of downsides to heparin bridging around device surgery
T34	Procedure 1357 1419	example in the Implantable Cardiac Pulse Generator Replacement
T35	Procedure 1608 1631	complete system removal
T36	Procedure 1857 1891	the prothrombotic state of surgery
T37	Procedure 1999 2069	defibrillator surgery without interruption of warfarin anticoagulation
T38	Procedure 2220 2291	Warfarin for Device Surgery Randomized Controlled Trial (BRUISE CONTROL
T39	Procedure 2456 2475	The primary outcome
T40	Procedure 2646 2695	. Major surgical and thromboembolic complications
T41	Procedure 2766 2796	1 episode of cardiac tamponade
T42	Procedure 2957 3010	those in a meta-analysis of the observational studies
T43	Procedure 3074 3121	device surgery without interruption of warfarin
T44	Procedure 3254 3271	dabigatran 150 mg
T45	Procedure 3289 3325	a creatinine clearance of 46 mL/ min
T46	Procedure 3369 3401	use for the prevention of stroke
T47	Procedure 3610 3651	1. Temporary interruptions for procedures
T48	Procedure 3780 3801	defibrillator surgery
T49	Procedure 4041 4114	the Table for suggested period of NOAC interruption before device surgery
T50	Procedure 4568 4619	the first dose of dabigatran 24 hours after surgery
T51	Procedure 4703 4725	48 hours after surgery
T52	Procedure 4760 4825	all of these recommendations about NOAC management around surgery
T53	Disease_disorder 41 60	atrial fibrillation
T54	Disease_disorder 48 60	fibrillation
T55	Disease_disorder 71 85	embolic stroke
T56	Disease_disorder 79 85	stroke
T57	Disease_disorder 87 104	diabetes mellitus
T58	Disease_disorder 87 95	diabetes
T59	Disease_disorder 106 118	hypertension
T60	Disease_disorder 136 150	cardiomyopathy
T61	Disease_disorder 166 185	atrial fibrillation
T62	Disease_disorder 173 185	fibrillation
T63	Disease_disorder 190 214	left bundle-branch block
T64	Disease_disorder 195 214	bundle-branch block
T65	Disease_disorder 209 214	block
T66	Disease_disorder 902 910	hematoma
T67	Disease_disorder 952 960	hematoma
T68	Disease_disorder 1030 1039	hematomas
T69	Disease_disorder 1294 1302	hematoma
T70	Disease_disorder 1342 1351	infection
T71	Disease_disorder 1456 1466	infections
T72	Disease_disorder 1518 1527	hematomas
T73	Disease_disorder 1543 1553	infections
T74	Disease_disorder 1827 1845	hypercoagulability
T75	Disease_disorder 2277 2283	BRUISE
T76	Disease_disorder 2503 2511	hematoma
T77	Disease_disorder 2746 2750	arms
T78	Disease_disorder 2779 2796	cardiac tamponade
T79	Disease_disorder 2803 2824	myocardial infarction
T80	Disease_disorder 2814 2824	infarction
T81	Disease_disorder 2860 2866	stroke
T82	Disease_disorder 2873 2898	transient ischemic attack
T83	Disease_disorder 2883 2928	ischemic attack in the continued-warfarin arm
T84	Disease_disorder 3395 3401	stroke
T85	Disease_disorder 3415 3423	embolism
T86	Disease_disorder 3441 3460	atrial fibrillation
T87	Disease_disorder 3448 3460	fibrillation
T88	Disease_disorder 3944 3950	stroke
T89	Disease_disorder 3960 3968	embolism
T90	Disease_disorder 4476 4485	hematomas
T91	Disease_disorder 18 60	a 76-year-old man with atrial fibrillation
T92	Disease_disorder 62 85	previous embolic stroke
T93	Disease_disorder 87 104	diabetes mellitus
T94	Disease_disorder 124 150	nonischemic cardiomyopathy
T95	Disease_disorder 166 254	atrial fibrillation and left bundle-branch block with a QRS duration of 180 milliseconds
T96	Disease_disorder 843 910	a substantial risk of clinically significant device pocket hematoma
T97	Disease_disorder 940 974	The risk of hematoma with bridging
T98	Disease_disorder 1016 1039	device pocket hematomas
T99	Disease_disorder 1271 1312	an association between hematoma formation
T100	Disease_disorder 1317 1351	subsequent device system infection
T101	Disease_disorder 1440 1466	8 patients with infections
T102	Disease_disorder 1504 1527	postoperative hematomas
T103	Disease_disorder 1529 1553	Device system infections
T104	Disease_disorder 1822 1845	even hypercoagulability
T105	Disease_disorder 2220 2291	Warfarin for Device Surgery Randomized Controlled Trial (BRUISE CONTROL
T106	Disease_disorder 2491 2511	significant hematoma
T107	Disease_disorder 2766 2796	1 episode of cardiac tamponade
T108	Disease_disorder 2801 2852	1 myocardial infarction in the heparin-bridging arm
T109	Disease_disorder 2858 2866	1 stroke
T110	Disease_disorder 2871 2928	1 transient ischemic attack in the continued-warfarin arm
T111	Disease_disorder 3369 3401	use for the prevention of stroke
T112	Disease_disorder 3406 3460	systemic embolism in patients with atrial fibrillation
T113	Disease_disorder 3951 3968	systemic embolism
T114	Disease_disorder 4443 4485	result in significant numbers of hematomas
T115	Sign_symptom 264 298	left ventricular ejection fraction
T116	Sign_symptom 281 289	ejection
T117	Sign_symptom 1274 1285	association
T118	Sign_symptom 1734 1741	problem
T119	Sign_symptom 1792 1798	normal
T120	Sign_symptom 2892 2898	attack
T121	Sign_symptom 3415 3423	embolism
T122	Sign_symptom 3960 3968	embolism
T123	Sign_symptom 4254 4264	hemostasis
T124	Sign_symptom 4800 4810	management
T125	Sign_symptom 260 298	his left ventricular ejection fraction
T126	Sign_symptom 1271 1312	an association between hematoma formation
T127	Sign_symptom 1723 1763	The second problem with heparin bridging
T128	Sign_symptom 1781 1812	a phase of normal coagulability
T129	Sign_symptom 2871 2928	1 transient ischemic attack in the continued-warfarin arm
T130	Sign_symptom 3406 3460	systemic embolism in patients with atrial fibrillation
T131	Sign_symptom 3951 3968	systemic embolism
T132	Sign_symptom 4760 4825	all of these recommendations about NOAC management around surgery
T133	Anatomical_structure 41 47	atrial
T134	Anatomical_structure 166 172	atrial
T135	Anatomical_structure 190 208	left bundle-branch
T136	Anatomical_structure 202 237	branch block with a QRS duration of
T137	Anatomical_structure 202 208	branch
T138	Anatomical_structure 457 464	cardiac
T139	Anatomical_structure 1384 1391	Cardiac
T140	Anatomical_structure 2746 2750	arms
T141	Anatomical_structure 2779 2786	cardiac
T142	Anatomical_structure 2849 2852	arm
T143	Anatomical_structure 2925 2928	arm
T144	Anatomical_structure 3441 3447	atrial
T145	Medication 226 234	duration
T146	Medication 1169 1177	duration
T147	Medication 3029 3034	basis
T148	Medication 166 254	atrial fibrillation and left bundle-branch block with a QRS duration of 180 milliseconds
T149	Medication 1165 1207	the duration and cost of hospitalization 7
T150	Medication 3025 3048	the basis of these data
